Status:

WITHDRAWN

Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Alzheimer Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Alzheimer's Plan 2008-2012 allowed the installation of therapeutic gardens for the structures welcoming patients with Alzheimer's disease (AD) . The physical, psychological and social benefits are...

Eligibility Criteria

Inclusion

  • Patient with AD in the mild to moderate stage, followed at the memory and resource center (CMRR) (MMS 15-23) and having had a 18F-FDG PET-CT (Positon emission tomography) scan in routine care having a companion for the duration of the study .
  • Patient with a neuropsychological assessment (MOCA, DO80, BREF, HAD) of less than 3 months. (If the last neuropsychological assessment dates from more than 3 months, these tests are carried out in routine care during the consultation was proposed and the consent obtained)
  • Symptomatic treatment of AD (anticholinesterase or memantine) if prescribed, at a stable dose for 1 month, stable psychotropic treatment for 1 month
  • Person affiliated with a social security scheme or beneficiary of such a scheme.
  • Patient over 18 years old.
  • Person received complete information on the organization of the research and having signed their informed consent.

Exclusion

  • Patient who did not have biomarkers identified by lumbar puncture
  • Patient unable to perform a cerebral 18F-FDG PET-CT scan (lying position for more than 20 minutes)
  • Patient unable to follow the therapeutic program of the garden.
  • Woman of childbearing age whitout effective contraception.
  • Pregnant woman or nursing mother.
  • Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health code.
  • Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric treatment under articles L. 3212-1 and L. 3213-1

Key Trial Info

Start Date :

August 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 2 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04514328

Start Date

August 2 2022

End Date

January 2 2023

Last Update

August 24 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT | DecenTrialz